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Historically, spontaneous deletions and insertions
have provided means to probe germline develop-
mental genetics in Drosophila, mouse and other
species. Here, induced pluripotent stem cell (iPSC)
lines were derived from infertile men with deletions
that encompass three Y chromosome azoospermia
factor (AZF) regions and are associated with produc-
tion of few or no sperm but normal somatic develop-
ment. AZF-deleted iPSC lines were compromised in
germ cell development in vitro. Undifferentiated
iPSCs transplanted directly into murine seminiferous
tubules differentiated extensively to germ-cell-like
cells (GCLCs) that localized near the basement
membrane, demonstrated morphology indistin-
guishable from fetal germ cells, and expressed
germ-cell-specific proteins diagnostic of primordial
germ cells. Alternatively, all iPSCs that exited tubules
formed primitive tumors. iPSCs with AZF deletions
produced significantly fewer GCLCs in vivo with
distinct defects in gene expression. Findings indi-
cate that xenotransplantation of human iPSCs
directs germ cell differentiation in a manner depen-
dent on donor genetic status.INTRODUCTION
Much progress has been made in recent years in elucidating
the molecular genetic requirements of germline formation and
differentiation in diverse organisms, including studies focused
on murine germline development in vivo and in vitro from mouse
embryonic stem cells (mESCs). Studies indicate that a key set
of transcriptional regulators, including Prdm1, Prdm14, and
Tfap2c, comprises a tripartite transcriptional core that functions1284 Cell Reports 7, 1284–1297, May 22, 2014 ª2014 The Authorsin suppression of somatic fate and acquisition of germline fate
in vivo (Magnu´sdo´ttir et al., 2013). In vitro studies have similarly
demonstrated that induced expression of these factors converts
mouse epiblast-like cells (mEpiLCs) to primordial germ-cell-like
cells (PGCLCs); moreover, Prdm14 appears to be sufficient for
this activity (Nakaki et al., 2013). The resulting PGCLCs are
capable of contributing to spermatogenesis and fertile offspring
following transplantation to murine seminiferous tubules (Haya-
shi et al., 2011, 2012). In parallel, in other studies, EpiSCs were
shown to have an infinite capacity for generating PGCLCs as
long as conditions were maintained to sustain pluripotency and
self-renewal in vitro (Hayashi and Surani, 2009).
Incontrast tomousegermlinedevelopment,much less isknown
of the genetic and molecular requirements to establish the popu-
lation of PGCs that ultimately gives rise to human sperm and
oocytes. Indeed, this is in spite of the fact that infertility is remark-
ably common, affecting 10%–15%of couples (Skakkebaek et al.,
1994). Moreover, genetic causes of infertility are surprisingly
prevalent among men, most commonly due to the de novo
deletion of one or more AZF (azoospermia factor) regions of the
human Y chromosome (Reijo et al., 1995, 1996; Vogt et al.,
1996; Foresta et al., 2000; Kuroda-Kawaguchi et al., 2001; Ferlin
et al., 2003; Hopps et al., 2003; Navarro-Costa et al., 2010). Pure
sterile phenotypes in men with deletions vary from the complete
absence of germ cells and sperm (termed Sertoli cell-only [SCO]
syndrome) to production of germ cells that arrest in development
(early maturation arrest; EMA) to very low sperm counts (oligo-
spermia) (Skakkebaek et al., 1994; Reijo et al., 1995, 1996). It
is not knownwhether the genesof theYchromosomeAZF regions
are required for PGC formation, maintenance of germline stem
cell populations, and/or commitment to later stages of meiosis
and haploid germ cell morphogenesis. Because of the unique
nature of Y chromosome gene content in men, studies that probe
the function of genes that map to the AZF regions must be
conducted on a human genome background.
In order to recapitulate human germ cell formation in vivo, we
tested the hypothesis that the somatic niche of murine seminifer-
ous tubules can direct formation and maintenance of GCLCs
from undifferentiated human induced pluripotent stem cells
(iPSCs). This hypothesis seemed reasonable given the extensive
similarity between ESCs/iPSCs and PGCs in terms of pluripo-
tency and gene expression and given that in both undifferenti-
ated human ESCs (hESCs) and human iPSCs, PRDM14, the
key inducer of PGC fate in mice, is very highly expressed and
only reduced upon somatic differentiation (Chia et al., 2010).
Thus, we generated patient-specific iPSCs from infertile men
that harbor the most common genetic deletions of the AZF re-
gions and then we induced germ cell formation from these iPSCs
via xenotransplantation. Our studies offer a strategy for probing
the function of naturally occurring mutations in germ cell devel-
opment that is analogous to strategies used historically in spe-
cies such as Drosophila.
RESULTS
Derivation and Characterization of iPSCs from
Azoospermic Men with Y Chromosome Deletions
iPSC lines were derived from dermal fibroblasts from five males;
lines were analyzed for Y chromosome deletions, and a deletion
map was constructed (Figure 1A and Table S1). We verified that
the fertile controls (AZF1 and AZF2) had intact Y chromosomes,
whereas all three infertile patients had deletions: one had a
complete deletion of the AZFa region (AZFDa); the second, a
deletion of both the AZFb and AZFc regions (AZFDbc); and the
third, an AZFc deletion (AZFDc). The men with AZFDa and
AZFDc deletions presented with SCO syndrome and had no
germ cells found in their testes upon extensive clinical examina-
tion; AZFDbc was severely oligospermic. iPSCs generated from
fibroblast cell lines (iAZF1, iAZF2, iAZFDa, iAZFDbc, and
iAZFDc) were isogenic with the parental fibroblast samples; no
additional deletions occurred as a consequence of reprogram-
ming. All iPSC lines met classic criteria of pluripotency (Figures
1 and S1). They expressed pluripotency markers at the mRNA
and protein levels (Figures S1B and 1B), were karyotypically
normal (Figure S1C; except for the presence of Y chromosome
deletions as indicated), and differentiated in vitro and in vivo to
cells of all three germ layers (Figures 1C and 1D).
In Vitro Differentiation of PGCs from Azoospermic Men
and Controls
We and others previously reported germ cell differentiation from
both hESCs and iPSCs in vitro (Clark et al., 2004; Kee et al., 2006,
2009;Park et al., 2009;Panula et al., 2011;Gkountela et al., 2013).
To assess germcell development fromazoospermicmen relative
to controls, we introduced a VASA:GFP reporter into all iPSCs,
differentiated cells, and enriched for presumptive VASA:GFP+
single-germ cells via FACS (fluorescence-activated cell sorting).
We observed that the percentage of GFP+ cells across all lines
was similar (2%–8%) as determined from two independent
clones per line (Figures S2A–S2E) but that germ cells differed in
gene expression as a function of genotype. First, to determine
similarities and differences between single cells differentiated
from each of the four cell lines, we performed hierarchical clus-
tering on single-cell expression (150–160 cells) and constructed
a condensed heatmap of 25 single cells (iPGCs) expressing
VASA andGFPmRNAs (Figure S2F). To evaluate germ-cell-spe-Ccific gene expression of in-vitro-derived PGCs (iPGCs) fromeach
line, we validated the identity of 50 individual cells that expressed
the GFP transcript (Figure 2A) and queried expression of germ
cell genes in a subset of cells for each line. Downregulation of
key pluripotency genes and expression of VASA and other clas-
sical humanPGCgenes such asDAZL is considered indicative of
a distinct PGC fate of iPSCs andhESCs following germcell differ-
entiation in vitro (Kee et al., 2009; Gkountela et al., 2013).
We observed that iPGCs derived from all five lines expressed
PRDM1, PRDM14, and DAZL mRNAs (Figure 2A). This was also
reflected at the protein level for DAZL in GFP+ cells (Figure 2B).
However, the overall number of cells expressing VASA, STELLA,
IFITM3, and NANOS3 genes varied across the lines, with the
greatest number observed in iAZF1-derived iPGCs compared
to AZF-deleted iPGCs (Figure 2A). Moreover, we noted that
GFP+ cell populations derived from iAZFDa and iAZFDbc lines
contained the fewest number of cells expressing at least seven
germ-cell-specific genes. At the protein level, iPGCs expressed
VASA, STELLA, and DAZL, but we detected fewer cells positive
for each protein in iAZFDc, iAZFDbc, and iAZFDa cells relative to
controls (Figure 2B). For all iPGCs derived, core pluripotency
genes were expressed at very low levels relative to undifferenti-
ated cells (Figure 2A, right). Moreover, linear discrimination anal-
ysis of 12 candidate germ cell genes (Tables S2 and S3) in each
population of GFP+ single cells revealed that iAZF1 and iAZFDc
iPGCs were distinct from iAZFDbc and iAZFDa iPGCs (Fig-
ure 2C). To further quantify these observations, we determined
the percentage of VASA+/GFP+ cells expressing between 1
and 12 candidate germ cell genes and observed that iAZF1
GFP+ cells expressed a minimum of 5–8 germ cell genes in
70% of the cell population (Figure 2D, left column, dashed lines).
By comparison, 70% of GFP+ single cells from each of the three
AZF-deleted lines expressed a range of only one to six germ cell
genes with the iAZFDa and iAZFDbc lines expressing the fewest
germ-cell-specific genes within single cells. Further analysis of
stage-specific gene expression revealed that, independent of
genotype, the majority of GFP+ iPGCs expressed at least four
to six PGC markers (Figure 2D, right column). In contrast, AZF-
deleted germ cells, particularly from iAZFDbc and iAZFDa,
expressed zero to two spermatogonial markers, whereas
iAZF1 expressed two to four spermatogonial genes (Figure 2D).
On the basis of germ-cell-specific gene expression at single-cell
resolution, these analyses suggest that all lines can differentiate
to iPGCs regardless of genetic background. However, when
iAZFDa and iAZFDbc cells are differentiated, fewer germ cells
are produced relative to control iAZF1 cells.
Transplantation and Survival of Fetal Germ Cells to
Murine Seminiferous Tubules
The gold standard for phenotypic characterization of stemcells is
assessment of function in vivo (Hanna et al., 2007; Nelson et al.,
2009;Weissman, 2012; Takahashi andYamanaka, 2013). As pre-
viously reported, in transplantation with human spermatogonial
stem cells, germ cells migrate to the seminiferous tubule base-
ment membrane and proliferate to form chains and patches of
spermatogonia that persist long term but do not appear to initiate
or complete meiosis (Nagano et al., 2002; Hermann et al., 2010;
Dovey et al., 2013). To date, the fate of human pluripotent stemell Reports 7, 1284–1297, May 22, 2014 ª2014 The Authors 1285
Figure 1. Derivation and Characterization of iPSCs from AZF-Intact and AZF-Deleted Patient Fibroblasts
(A) Genotype-phenotype map to visualize deletion of AZFa, AZFb, and AZFc regions in hESC lines, patient samples, and patient-derived iPSCs used for this
study. A deletion map was constructed for every hESC line, patient fibroblast, and iPSC line by testing for the presence of 20 major STSs by PCR. Vertical black
bars (top) represent the STS amplification regions and genes we used to diagnose AZFa, AZFb, and AZFc deletions. Gray boxes represent the deleted regions of
the Y chromosome. The fertility phenotype (left; SCO and EMA) and karyotype (right) of each patient are listed. The triangle symbol (D)indicates the deletion of an
AZF region in that cell line.
(B) Immunocytochemistry in all patient-derived iPSC lines for nuclear (OCT4 and NANOG) and cell surface (SSEA1/SSEA3/SSEA4, TRA1–60, and TRA1–81)
markers of pluripotency.
(C) In vitro differentiation of four patient-derived lines to cells representative of all three germ layers: AFP, a-fetoprotein; bIII-Tub, b-III-tubulin/Tuj1; SMA, smooth
muscle actin.
(D) In vivo teratoma formation of iAZFDbc, iAZFDc, and iAZFDa lines showing evidence of all three germ layers. e, endoderm; ep, gut-like epithelium; m,
mesoderm; sm, smooth muscle-like mesoderm; c, cartilage-like; ec, ectoderm; ne, neural ectoderm.
See also Figure S1 and Table S1.
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cells in themouse seminiferous tubule has not been explored. To
verify that human germ cells could survive and engraft insidemu-
rine seminiferous tubules, we transplanted human fetal testicular
cell suspensions (22 weeks old) into busulfan-treated testes of
immunodeficient mice (Figure 3A). The use of busulfan treatment
eliminates endogenous mouse germ cells from the seminiferous
tubules (Figure 3B). Prior to transplantation, we observed that the
22-week-old human fetal testis contained a subset of cells pos-
itive for the germ-cell-specific protein VASA (Figure 3Ci). Using
whole-mount staining analyses, we immunostained with a pri-
mate-specific antibody that is known to recognize all human
donor cells only (regardless of germ cell fate) and, consistent
with reports on adult testis transplants, observed single-donor
cells, small chains (Figure 3Cii), or larger clusters of human donor
cells on the basement membrane 2 months posttransplantation.
In parallel, we also performed immunohistochemistry in cross-
sections of testes transplanted with human fetal testis cells. In
order to detect all human donor cells in recipient testes, we as-
sessed expression of NuMA (Figure 3D), a well-characterized
protein that exclusively labels human cells and tissues (Abad
et al., 2007; Bru¨ning-Richardson et al., 2012; Saadai et al.,
2013). We observed significant human germ cell engraftment
8 weeks posttransplantation (Figure 3Ciii).
Xenotransplantation of hESCs and Human iPSCs to
Seminiferous Tubules Directs Germ Cell Development
As noted above, we hypothesized that human iPSCs, which
are distinct from mouse iPSCs (miPSCs), would survive, engraft,
and be directed to a germ cell developmental fate if directly
injected into the mouse seminiferous tubule, in response to
instructive cues from the niche. Thus, we next transplanted
undifferentiated male hESCs (H1) and the iAZF1 control iPSCs
to eight recipient testes each and analyzed results by whole-
mount immunohistochemistry as performed previously with
human fetal testis transplants (Figure 3A). We observed that all
donor-derived cells were detected either as single cells or in
clusters of cells; no clear evidence of chain-like structures was
observed (Figure S3B). We note that chain formation in human
donor cells is a hallmark of spermatogonia but is not a property
of PGCs and gonocytes (Nagano et al., 2002; Wu et al., 2009).
Thus, we reasoned that engrafted cells might have differentiated
to PGCLCs or gonocyte-like cells and tested systematically for
the presence of germ-cell-specific proteins on NuMA+ surviving
donor cells using serial immunohistochemical analysis across
testis cross-sections. We observed that all transplantations,
regardless of fertility status, resulted in two fates of donor undif-
ferentiated iPSCs in the testes: (1) differentiation to GCLCs that
were spatially located near or at the basement membrane of
seminiferous tubules and (2) extensive proliferation of iPSCs
distant from the basement membrane most often within the
interstitial space. These proliferative cells resembled embryonal
carcinoma (EC) and yolk sac tumors (YSTs).
Upon further analysis of H1 and iAZF1 xenotransplants, and as
expected, we observed that a subset of tubules was occupied
with NuMA+ donor cells (Figures S3C–S3I). In tubules containing
donor cells, NuMA+ donor cells engrafted both near the base-
ment membrane and in the center of the tubule. A significant
number of NuMA+ cells coexpressed the germline protein,CVASA (henceforth referred to as NuMA+/VASA+ cells) (Figure 3E,
white asterisks). We also observed that a fewNuMA+ cells nega-
tive for VASA engrafted at the edges of seminiferous tubules
(Figure 3E, red asterisk). To exclude the possibility that NuMA+
donor cells could differentiate to Sertoli cells, we costained for
GATA4 and SOX9, two nuclear proteins expressed by mouse
and human Sertoli cells (Figure S4).We did not observe the local-
ization of SOX9 and GATA4 signals in nuclei of NuMA+ cells (Fig-
ures S4A and S4D), but only in cells that resemble human or
mouse Sertoli cells at the edge of most tubules (Figures S4B,
S4C, and S4E). Based on these results, we defined human
GCLCs by the presence of NuMA+ cells that engrafted near
the basement membrane of seminiferous tubules, colocalization
of germ cell markers, especially VASA, and overall morpholog-
ical resemblance to human fetal germ cells (Figure 3E). By com-
parison, staining of human fetal testis cross-sections revealed
VASA+ germ cells near the tubule basement membrane (Fig-
ure 3Ci). Specifically, in testis xenografts, a large number of
NuMA+/VASA+ cells localized to the basal membrane of the
tubule either as single cells, rows or in clusters that bear clear
resemblance to the arrangement of VASA+ germ cells of the hu-
man fetal testis (Figures 3E and 4A–4F).
Male Donor-Derived Cells Engrafted Outside
Spermatogonial Tubules Remain Undifferentiated or
Differentiate to Primitive Tumors
As noted above, in addition to cells that engrafted at the base-
ment membrane, we observed that donor cells that filled the
entire seminiferous tubule or exited the tubule proliferated exten-
sively and did not demonstrate clear differentiation to either
GCLCs or somatic cells. Instead, based on histology of xeno-
grafts, cells distant from the basement membrane, outside the
tubules, resembled the histology of EC or, in some instances,
YST cells (Figure S5A; Chaganti and Houldsworth, 2000; Non-
aka, 2009). To verify, we stained xenografts for SOX2 and
OCT4, protein markers diagnostic, at least in part, for EC forma-
tion and undifferentiated cells (Nonaka, 2009). We observed
extensive SOX2 and OCT4 expression in NuMA+ nuclei in the
interstitial space (Figure S5B).We reasoned that these cells likely
resulted from leakage of donor hESCs and iPSCs from tubules
into the interstitial spaces of the testis. Notably, donor cells in
the interstitial spaces did not form teratomas as assessed by
thorough histological analysis, suggesting that they did not
receive the appropriate cues to differentiate to somatic lineages
or that somatic cells are efficiently removed following differenti-
ation. NuMA+ cells that filled the entire tubular space expressed
OCT4 but did not appear to form GCLCs (VASA negative), sug-
gesting that they remained undifferentiated (Figure S5C). We
determined the efficiency of interstitial tumor formation across
all testis xenografts performed and found that, except for human
fetal testis transplantation, hESC and iPSC xenotransplants
consistently produced interstitial tumors in more than half of all
samples (Figure S5D). Curiously, iAZFDc iPSCs produced inter-
stitial tumors only 30%of the time, but the tumors were always of
EC or YST types. Altogether, these results suggested that the
environment inside the seminiferous tubule is permissive for
germ cell formation but appears to prevent differentiation of
some donor cells to somatic lineages. In contrast, theell Reports 7, 1284–1297, May 22, 2014 ª2014 The Authors 1287
(legend on next page)
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environment outside the tubules promotes somatic differentia-
tion but not teratoma formation in donor cells that exited tubules.
Transplantation of iPSCs into Murine Seminiferous
Tubules Reveals Differences in Germ Cell
Differentiation between Control and AZF-Deleted Lines
We predicted that AZF-deleted iPSCs would form and/or main-
tain fewer GCLCs than AZF-intact iPSC lines. From our immuno-
histochemical analysis, we observed that transplanted human
fetal testis cells, H1 hESCs, iAZF1, iAZF2, and iAZFDc iPSCs
were usually localized in NuMA+/VASA+ clusters containing at
least three ormore cells (Figures 3E and4A–4D, arrows andwhite
asterisks). In contrast, iAZFDbc and iAZFDa iPSCs gave rise to
significantly fewer clusters of NuMA+/VASA+ cells (Figures 4E
and 4F, arrows and white asterisks). To quantify this observation
for each donor sample, we counted NuMA+/VASA+ cells and tu-
bules across entire cross-sections (203magnification) at three to
four different depths of cross-sections and in at least four biolog-
ical replicates per sample. Using this strategy, we extracted the
average percentage of positive seminiferous tubules (Figure 4G).
Although human fetal donor cells always produced the highest
percentage of positive tubules (>30%), both iAZF1 and iAZF2
lines produced significantly higher tubule occupancy over AZF-
deleted iPSCs (Figure 4G).Wenext determined the average num-
ber of NuMA+/VASA+ cells in each positively stained tubule (Fig-
ure 4H). We determined that, on average, >30 NuMA+/VASA+
cells per tubule were observed with human fetal donor cells
and approximately 20–25 NuMA+/VASA+ cells per tubule with
human iAZF1 and iAZF2 donor cells. These values were signifi-
cantly higher than those observed in the case of iAZFDa,
iAZFDbc, and iAZFDc donor cells, where we observed four to
eight NuMA+/VASA+ cells per tubule (Figure 4H). To determine
the relative germ-cell-forming potential of each donor cell popu-
lation, we multiplied the tubule occupancy (per 100 tubules) by
NuMA+/VASA+ cells per tubule (Figure 4I). Our calculations
reveal an approximate 50- to 100-fold reduction in formation of
GCLCs from AZF-deleted iPSCs relative to AZF-intact iPSCs.
To further validate in vivo GCLC formation fromdonor cells, we
examined expression of the germ-cell-specific proteins DAZL,
PLZF, UTF1, STELLA, and DAZ in donor-derived GCLCs from
xenotransplants (Figures 5 and S6). Based on previous reports,
we predicted that STELLA, DAZL, and VASA would label iPSCs
that had differentiated to PGCLCs, whereas UTF1, PLZF, andFigure 2. Derivation and Characterization of iPGCs from AZF-Intact an
(A) Single-cell gene expression of VASA-GFP+ iPGCs derived from undifferentia
iAZFDbc, and iAZFDa). The relative expression of PGC genes PRDM1, PRDM1
normalization in all cells positive forGFPmRNAandplotted individually. Expression
graph. Each vertical bar represents 1 individual cell, and at least 25 cells are repre
legend colors for sample identification. A heat index of pluripotency gene expressio
(B) Immunocytochemistry of GFP+ sorted cells for GFP and PGC proteins VASA
represent 25 mm.
(C) Two-component linear discrimination analysis of all single-cell RT-PCR mea
represents one single-cell measurement.
(D) Percentage of GFP+ sorted single cells coexpressing 12 additional germ-cel
each individual cell. Dashed, vertical lines indicate the segment of the population
population. Coexpression of nine PGC (blue) and six gonocytic/spermatogonia
respective markers within each cell.
See also Figure S2 and Tables S2 and S3.
CDAZ proteins would label iPSCs that had entered the pool of
gonocyte-like or prospermatogonia-like cells and would overlap
with expression of VASA (Buaas et al., 2004; Anderson et al.,
2007; Kristensen et al., 2008; Culty, 2009; Phillips et al., 2010;
Wongtrakoongate et al., 2013). Fetal testes at 22weeks of gesta-
tion are expected to contain gonocytes and undifferentiated
spermatogonia (Culty, 2009). Interestingly, fetal germ cells
expressed DAZL, STELLA, and UTF1 simultaneously (Fig-
ure S6A). NuMA+/VASA+ cells derived from human fetal testis
donor cells expressed the PGC proteins STELLA and DAZL in
a similar nuclear and cytoplasmic pattern, respectively, to
endogenous germ cells in the human fetal testis (Figure 5A, panel
1, and Figure S6A). Similarly, NuMA+/VASA+ cells derived from
all AZF-intact and AZF-deleted donor lines expressed STELLA
and DAZL proteins (Figures 5B–5F, panel 1). We further
observed that expression of UTF1, PLZF, and DAZ proteins
varied between donor cell lines dependent on genotype. In the
control human fetal testis, UTF1, PLZF, and DAZ proteins were
expressed in a few GCLCs in a subset of seminiferous tubules
(Figure S6A). In a similar fashion to the fetal testis, UTF1 was
localized in several DAZL+ donor-derived germ cells near the
edges of tubules in all samples except iAZFDbc and iAZFDa,
where we could not detect UTF1 signals (Figures 5A–5D, panel
2, and Figure S6). In addition, the prospermatogonial protein
PLZF was detected in only a handful of VASA+ cells in iAZF1 xe-
nografts, but not in other samples (Figure 5C, panel 2).We further
observed that none of the three AZF-deleted lines expressed the
Y chromosome-encoded protein DAZ. In contrast, we detected
cytoplasmic expression of DAZ proteins in NuMA+ cells of AZF-
intact donor cells (H1, iAZF1, and iAZF2) and donor cells from the
human fetal testis (Figures 5G and S6B). The pattern of DAZ
expression closely corresponded to that of endogenous fetal
germ cells in the human testis (Figure S6A). Collectively, results
indicate that the human fetal testis donor cells and all patient-
derived iPSCs are capable of forming PGCLCs but that, in
general, AZF-deleted iPSCs form fewer GCLCs with altered
expression of germ-cell-specific proteins (Figure 5H).
Epigenetic Analysis of Donor-Derived GCLCs from AZF-
Intact iPSCs
In order to evaluate if epigenetic reprogramming, characteristic of
endogenous germ cells, occurs in donor iPSC xenografts, we
performed immunohistochemistry for 5-methylcytosine (5-mC)d AZF-Deleted iPSCs In Vitro
ted AZF-intact iPSCs (iAZF1), hESCs (H1), and AZF-deleted iPSCs (iAZFDc,
4, DAZL, STELLA (DPPA3), IFITM3, NANOS3, and VASA was measured after
levels in undifferentiated single cells fromeach iPSC line are also shown in each
sented for differentiated samples and 20 cells for undifferentiated samples. See
n in five differentiated single cells and in undifferentiated iPSCs is shown (right).
, STELLA, and DAZL. Nuclei are counterstained with DAPI (blue). Scale bars
surements for 27 germ cell genes from all iPSC lines tested. Each single dot
l-associated genes (see Table S3) as plotted by the number of markers within
of single cells from each line relative to the middle 70%–80% of control, iAZF1
l genes (red) was quantified in GFP+ iPGCs and plotted by the number of
ell Reports 7, 1284–1297, May 22, 2014 ª2014 The Authors 1289
Figure 3. Survival and Germ Cell Differentiation of Fetal Germ Cells, hESCs, and iPSCs after Transplantation to Mouse Spermatogonial
Tubules
(A) Transplantations were performed by independently injecting 22-week-old human fetal testicular cells, H1 hESCs, or human iPSCs directly into seminiferous
tubules of busulfan-treatedmouse testes (pink oval) that were depleted of endogenous germ cells. Testis xenografts were analyzed by (1) whole-mount histology
using a human cell-specific antibody, or (2) immunohistochemistry using a human cell-specific antibody, NuMA, to detect donor cells.
(B) Hematoxylin and eosin histology of normal mouse recipient testes before busulfan treatment, after busulfan-mediated germ cell depletion, and 2 months
posttransplantation of iPSCs.
(C) Human (Hu) fetal testis (22 weeks old) with cytoplasmic VASA expression (green) in germ cells (i). Nuclei are counterstained with DAPI. Human fetal testis was
enzymatically dissociated, and fetal germ cells were transplanted and then detected after 2 months by (ii) whole-mount staining or (iii) cross-sectional immu-
nohistochemistry for NuMA+/VASA+ cells (white asterisks).
(D) Human and mouse immunostaining controls for NuMA antibody specificity.
(E) Immunohistochemical analysis of testis xenografts derived from undifferentiated (i and ii) H1 hESC and (iii and iv) iAZF1 iPSCs. All images are merged from
NuMA (red), VASA (green), and DAPI-stained nuclei. White rectangles indicate regions of interest of positive colocalization of NuMA and VASA and are magnified
in (ii) and (iv). Red asterisks indicate NuMA+ donor cells adjacent to the basement membrane, whereas white asterisks represent NuMA+/VASA+ donor cells near
the basement membrane.
In all panels, dashed white lines indicate the outer edges of spermatogonial tubules. Scale bars represent 50 mm. See also Figure S3.as a marker of global CpGmethylation. We compared 5-mC sta-
tus in endogenousgermcells of both human fetal andadult testes
(Figures 6A and 6B) and in all recipient mouse testis xenografts
(Figures 6C–6G). We observed that a majority of endogenous1290 Cell Reports 7, 1284–1297, May 22, 2014 ª2014 The AuthorsVASA+ germ cells in fetal testes were 5-mC positive, with a sub-
set of VASA+ cells 5-mC negative (Figure 6A, yellow arrowheads
and white dotted circles, respectively). Intriguingly, NuMA+/
VASA+ cells in all xenografts derived from human fetal testis
Figure 4. Differences in GCLC-Forming Po-
tential between Patient-Derived iPSCDonor
Cells in Mouse Spermatogonial Tubules
(A–F) Mouse testis xenografts were analyzed by
immunohistochemistry using the human cell-
specific antibody NuMA and an antibody recog-
nizing the pan-germ cell marker VASA, marking
PGCs, gonocytes, and spermatogonia. Cross-
sections of testis xenografts derived from (A) 22-
week-old human fetal testis cells, (B) iAZF1, (C)
iAZF2, (D) iAZFDc, (E) iAZFDbc, and (F) iAZFDa
cell lines. All images are merged from NuMA (red),
VASA (green), and DAPI-stained nuclei. Arrows
indicate cells or clusters with positive colocaliza-
tion of NuMA and VASA. Red asterisks indicate
NuMA+ donor cells adjacent to the basement
membrane, whereas white asterisks represent
NuMA+ donor cells near the basementmembrane.
In all panels, dashed white lines indicate the outer
edges of spermatogonial tubules. Scale bars
represent 50 mm.
(G) Percentage of tubules positive for NuMA+/
VASA+ cells was calculated acrossmultiple cross-
sections (relative to total number of tubules).
(H) For each positive tubule, the ratio of NuMA+/
VASA+ cells per tubule was determined.
(I) Relative germ-cell-forming potential calculated
by multiplying the fraction of positively stained
tubules with the number of VASA/NUMA-cos-
tained cells for each sample. Data are represented
as mean ± SD of replicates. In each graph, sig-
nificant differences in percentages/ratios between
controls (iAZF1 or iAZF2) and AZF-deleted lines
were determined by one-way ANOVA. *p < 0.05;
**p < 0.001; ns, nonsignificant.
See also Figure S3.donor cells or iPSC lines exhibited similar numbers of cells nega-
tive or positive for 5-mC (Figures 6C–6G, yellow arrowheads and
white dotted circles, respectively). The 5-mC reduction was
confined to germ cells within tubules (i.e., NuMA+ donor cells
outside tubules were all 5-mC positive) (Figure 6H). Additionally,
undifferentiated iPSC donor cells in culture exhibited uniform
levels of 5-mC prior to transplantation (Figure 6H, bottom). In
addition to immunohistochemical analysis, we quantified the
pattern of 5-mC signals in NuMA+/VASA+ cells within tubules
and observed a fairly uniform percentage (15%–20%) of 5-mC-
negative cells in all xenografts, including those derived from hu-
man fetal testis donor cells. This observation mirrored the
approximate 25% of endogenous fetal testis germ cells that
were 5-mC negative (Figure 6I). Meanwhile, endogenous adult
testis germ cells were highly methylated (only 3%–5% 5-mC
negative). Collectively, our results suggest that human donorCell Reports 7, 1284–129cells undergo global DNA demethylation
upon initiation of germ cell differentiation
inside the mouse seminiferous tubule.
DISCUSSION
Amajor emphasis in stem cell biology and
regenerative medicine is focused oniPSC-derived cell transplantation to restore somatic cellular
and tissue function (Wu and Hochedlinger, 2011; Takahashi
and Yamanaka, 2013). Much less focus has been directed at
the use of human iPSCs to derive germ cells for potential cell
replacement therapies, despite elegant studies in the mouse
that demonstrate the ability to completely reconstitute mouse
germline development from ESCs and iPSCs (Hayashi et al.,
2011, 2012; Grabole et al., 2013; Nakaki et al., 2013). Both
mouse and human studies have demonstrated requirements
for key germ-cell-specific genes and dependence of germ cell
development on interaction with the niche (Nicholas et al.,
2009; Hayashi et al., 2011; Kee et al., 2009; Panula et al., 2011;
Easley et al., 2012; Medrano et al., 2012; Gkountela et al.,
2013). Yet, there are difficulties in interpreting the human data
given the low numbers of GCLCs formed in vitro, the extensive
overlap of gene expression shared between ESCs and PGCs7, May 22, 2014 ª2014 The Authors 1291
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such that fewer than a dozen genes may differ (Clark et al., 2004;
Zwaka and Thomson, 2005; Johnson et al., 2008; Sabour et al.,
2011), and the asynchrony in development of germ cells in vitro.
In this study, we observed that transplantation of normal and
AZF-deleted iPSCs into the environment of the seminiferous
tubule resulted in GCLC formation, whereas iPSCs outside the
tubules failed to differentiate to GCLCs. Based on these results,
we reason that iPSC and hESC donor cells inside seminiferous
tubules may receive signals that permit them to engraft near the
basement membrane. Our findings are supported by the obser-
vation that human spermatogonia transplanted to mouse testes
‘‘home’’ to the basement membrane but cannot differentiate to
more mature stages (Nagano et al., 2002; Wu et al., 2009; Taka-
shimaet al., 2011).We suggest that cell-to-cell contacts between
cells of the basement membrane niche, especially Sertoli cells,
and donor cells enable exchange of instructive signals. Further-
more, we suggest that this crosstalk favors acquisition of a
PGC- or gonocyte-like fate in human iPSCs with suppression of
extensive proliferation and somatic cell differentiation (Resnick
et al., 1992; Johnson et al., 2008; Kanatsu-Shinohara et al.,
2012). In a similar fashion, undifferentiated murine spermato-
gonia self-renew or differentiate based on Sertoli cell density
and factors secreted by Sertoli cells (Phillips et al., 2010; Oatley
et al., 2011). These Sertoli cell-produced factors include para-
crine growth factors such as transforming growth factor (TGF)
and stemcell factor (SCF), which have been implicated in the sur-
vival and/or differentiation of PGCs (Mullaney and Skinner, 1991;
Ewen and Koopman, 2010). In mice, the transition to epiblast
stemcells andoverexpression of Prdm14 facilitates germcell dif-
ferentiation posttransplantation (Nakaki et al., 2013). In contrast,
both undifferentiated hESCs andhuman iPSCs are believed to be
‘‘epiblast-like’’ and moreover express high levels of PRDM14
endogenously as shown in this manuscript and other reports by
Brons et al. (2007) and Tesar et al. (2007).
Our findings also bear some resemblance to reports in flies
where the somatic cyst cells, which are immediately adjacent
to germline stem cells, induce germline differentiation, whereas
perturbation of the niche:germ cell environment leads to exten-
sive proliferation resembling germ cell tumors (Karnis, 2012;
Lim and Fuller, 2012). Based on our results and previously pub-
lished studies, we posit that undifferentiated human iPSCs inside
murine seminiferous tubules receive critical molecular cues from
Sertoli cells and, potentially, from peri-tubular cells that assist in
localization and physical interaction, accessibility to signaling
cues, and ultimately direct germline differentiation. Moreover, if
the niche is ‘‘overbooked’’ and iPSCs leak out of tubules or areFigure 5. Donor-Derived GCLCs from H1, Human Fetal Testis, and iA
matogonia, whereas AZF-Deleted Donor Cells Only Express PGC Mark
(A–F) Mouse testis xenografts derived from (A) H1 hESCs, (B) 22-week-old hum
stained in adjacent, serial cross-sections for the PGC markers DAZL and STE
NuMA+VASA+ regions. For each xenograft, low-magnification regions of the semi
interest are enlarged and shown to the right. In NuMA+/VASA+ donor cells, im
immunostaining for DAZL (red) and STELLA (green); and Panel 2, UTF1 (green),
(G) Mouse testis xenografts derived from H1 hESCs, iAZF1, and human fetal test
enlarged in lower panels. In all panels, dashed white lines always indicate the oute
with DAPI (blue). Scale bar represents 50 mm.
(H) Summary of positive (green) and negative (red) germ cell protein expression
See also Figure S4.
Cnot able to contact Sertoli cells, we suggest that these cells
will proliferate extensively to form EC outside the tubule or
remain undifferentiated inside the tubule. Indeed, it is remarkable
that in sharp contrast to studies with miPSCs, human iPSCs and
hESCs never formed teratomas in our studies, perhaps due to
their transient interaction with the intratubular environment.
Historically, it has not been possible to address when or how
germ cells are depleted in men with spontaneous deletions;
heterogeneity of clinical phenotypes associated with the same
genetic deletions may be linked to depletion rate or time of
presentation (Reijo et al., 1995, 1996). Moreover, it was not
known whether AZF deletions might disrupt early germ cell
development or maintenance. Here, we observed that iPSCs
derived from men with AZFa and AZFbc deletions formed fewer
and poor-quality PGCLCs both in vitro and in vivo. Regardless of
genotype, however, we determined that human donor-derived
GCLCs are induced to undergo global DNA demethylation
from somatic methylation levels in amanner that is characteristic
of the development of male PGCs to gonocytes (Wermann et al.,
2010; Seisenberger et al., 2012). Importantly, our results indicate
that there is a clear defect linked to expression of later genes
such as DAZ, PLZF, and UTF1 that coexpress with or follow
expression of PGC markers (Culty, 2009); in particular, those
with AZF deletions did not express Y chromosome DAZ and
the genes UTF1 and PLZF in any germ cells. Thus, our results
of germ cell differentiation are well correlated with clinical
outcomes but also provide some interesting insights. However,
iPSCs formed PGCLCs, suggesting that men with these dele-
tions likely form germ cells early in development but that these
cells are depleted prior to clinical presentation. This concept is
consistent with many mouse models of infertility in which initial
populations of germ cells are not maintained (Modi et al., 2003;
Rucker et al., 2000). Indeed, in mice, both XX and XY embryos
form PGCs, which migrate to the gonad and begin differentiation
to sperm or oocytes, independent of germ cell sex chromosome
composition, depending on the sexual identity of the gonad
proper (Gill et al., 2011). Human genetic data similarly indicate
that the XO genotype (Turner syndrome) is compatible with for-
mation of fetal germ cells, but they are depleted by birth or there-
after (Modi et al., 2003; Karnis, 2012).
Our results have been summarized into a working model for
the efficiency and fate of human iPSCs during human germ cell
formation in the mouse testes (Figure 7). Further studies should
refine existing methods by performing transplantations with
varying cell numbers, examining genetic complementation
and hierarchy, and altering the xenotransplant recipient to aZF1 Exhibit Multiple Markers of PGCs and Undifferentiated Sper-
ers
an fetal testicular cells, (C) iAZF1, and (D–F) AZF-deleted human iPSCs were
LLA and for the gonocyte/spermatogonial markers UTF1, PLZF, and DAZ in
niferous tubule containingNuMA+VASA+ cells are shown, and boxed regions of
munostaining for germ cell proteins is shown as follows: Panel 1, positive
UTF1+DAZL, PLZF (green), or PLZF+VASA.
icular cells showing NuMA+ cells that coexpressed DAZ in boxed regions and
r edges of spermatogonial tubules. Wherever shown, nuclei are counterstained
across all xenografts tested.
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Figure 6. Global DNA Methylation Properties of Xenotransplanted iPSCs
Human fetal (22 weeks) testis (A), human adult testes (B), and mouse testis (C–G) xenografts derived from human fetal testicular cells and iPSCs were stained for
VASA and 5-mC in NuMA+ regions.
(A) Cross-section of a human fetal testis (22 weeks) with positive immunostaining for 5-mC alone or VASA and 5-mC together. Enlarged panels on the left
represent the region enclosed within the white rectangle of the right panel.
(B) Cross-section of a human adult testis with positive immunostaining for 5-mC alone or VASA and 5-mC together.
(C–G) Cross-sections of mouse testes transplanted with 22-week-old human fetal testicular cells (C) and undifferentiated iPSC donor cells from each line (D–G).
For each xenografted line, immunostaining for NuMA+/VASA+ cells (top), 5-mC alone (middle), and 5-mC together with VASA (bottom) is shown. White dotted
circles indicate NuMA+/VASA+ cells with complete loss of 5-mC signal; yellow arrowheads indicate NuMA+/VASA+ positive cells with positive 5-mC signals.
(H) Positive 5-mC signals in NuMA+ cells outside tubules (top) and in undifferentiated iPSCs prior to transplantation (bottom).
(I) Quantification of 5-mC positive and negative signals in human testes (left columns) and in NuMA+/VASA+ cells of testis xenografts (middle columns). 5-mC
patterns in extratubular NuMA+ cells are shown (right column).
In all panels, dotted lines indicate edges of spermatogonial tubules. Scale bars represent 50 mm. See also Figure S6.
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Figure 7. Schematic Illustration of Major Findings of This Study
iPSCs were derived from patients with AZF-intact and AZF-deleted Y chro-
mosomes using the OCT4, SOX2, KLF4, and CMYC cocktail (OSKM). When
transplanted, undifferentiatedmale iPSCs specifically differentiate to PGC-like
and gonocyte-like germ cells inside the mouse spermatogonial tubule envi-
ronment, presumably in the Sertoli cell niche. However, outside the tubule, all
patient-derived iPSCs and hESCs remain undifferentiated as primitive tumors.
AZF-deleted iPSCs appear to have a lower potential to make germ cells in vivo
as compared to AZF-intact iPSCs and appear to be restricted to forming
PGCLCs. See also Figure S5.nonhuman primate in order to promote full reconstitution of sper-
matogenesis and overcome innate barriers in xenotransplanta-
tion of human cells to the mouse.EXPERIMENTAL PROCEDURES
Derivation and Culture of iPSC Lines from Primary Human Skin Cells
The human skin-derived primary cell lines (AZF1, AZF2, AZFDa, AZFDbc, and
AZFDc) used in this study were obtained from a 4 mm adult skin punch biopsy
and cultured as described by Byrne et al. (2009). AZF2 iPSCs were derived
from normal human fetal foreskin fibroblasts (Stemgent) as previously
described (Durruthy Durruthy et al., 2014). Fibroblasts were allowed to expand
to 80%–90% confluency before passaging and cryopreservation. Deletion
mapping analysis of all patient-derived fibroblasts was determined by
sequence-tagged site (STS) PCR analysis with the Y Chromosome Deletion
Analysis Kit (Promega) according to manufacturer’s instructions. Dermal fibro-
blasts were infected with a polycistronic lentiviral-reprogramming vector as
previously described for reprogramming by Sommer et al. (2010) and Sebas-
tiano et al. (2011). Briefly, 105 fibroblasts were seeded in mouse embryonic
fibroblast (MEF) medium and infected. After 6 days, cells were transferred
onto inactivated MEFs. After replacement with hESC medium, the cells were
grown for up to 8 weeks until hESC-like colonies started to emerge. IPSC
colonies were manually picked, expanded on MEFs, and after approximately
15–20 passages, transferred to feeder-free culture conditions in mTeSR1
medium (STEMCELL Technologies).
Transduction, Differentiation, and FACS of iPSCs and hESCs with
VASA:GFP Reporter Lentivirus
Undifferentiated iPSCs and hESCs were transduced, selected, and differ-
entiated on Matrigel-coated plates with a VASA:GFP lentivirus as previ-
ously described by Kee et al. (2009) and Medrano et al. (2012). As con-
trols, transduced cells and nontransduced cells were also used in all
differentiation experiments. Differentiation medium was supplementedCwith 50 ng/ml bone morphogenetic proteins 4 and 8 (BMP4 and BMP8,
respectively), 10 nM retinoic acid (RA), and 2 ng/ml human recombinant
leukemia inhibitory factor (hLIF) and changed every 3.5 days. Cells were
sorted for GFP+ and GFP populations on a Becton Dickinson
FACSArias II instrument.
Xenotransplantation Assay
Human cell lines were transplanted into the testes of busulfan-treated,
immune-deficient nude mice (NCr nu/nu; Taconic) as previously described
for primate and human spermatogonia by Hermann et al. (2010). Briefly, immu-
nodeficient nude mice were treated with a single dose of busulfan (40 mg/kg;
Sigma-Aldrich) at 6 weeks of age to eliminate endogenous spermatogenesis.
Xenotransplantation was then performed 5 weeks after busulfan treatment by
injecting 7–8 ml cell suspensions containing 10% trypan blue (Invitrogen) into
the seminiferous tubules of each recipient testes via cannulation of the efferent
ducts. At 8 weeks after transplantation, recipient mouse testes were harvested
for histology and immunohistochemical analyses.
Immunohistochemistry
Formalin-fixed human testes or mouse testes xenotransplants were paraffin
embedded and sectioned into serial cross-sections of 5–10 mm thickness
each (AML Laboratories). Testis sections were deparaffinized in xylene,
rehydrated through an ethanol-graded series. For all samples, antigen
retrieval was performed by boiling the sections in 0.01 M sodium citrate
buffer (pH 6.0) for 20 min, followed by incubation at room temperature for
30 min. For DNA methylation analysis, sections were incubated in 4 N HCl
for 20 min prior to blocking. A 10% solution of normal donkey serum (Jack-
son ImmunoResearch) in PBS was used as a blocking buffer. Sections were
incubated with the following primary antibodies diluted in blocking solution
(1.0% Normal Donkey Serum, 0.1% Triton X-100, and sterile PBS) overnight
at 4C: VASA (1:200) and GFRa1 (1:250) (R&D Systems); NuMA (1:200),
STELLA (1:200), DAZL (1:200), and DAZ (1:250) (Abcam); UTF1 (1:200; Milli-
pore); PLZF (1:250; Chemicon); OCT4 (1:500), SOX2 (1:500), and GATA4
(1:250) (Santa Cruz Biotechnology); SOX9 (1:250; Sigma Aldrich); 5-mC
(1:1500; Eurogenetec); and 5-hMC (1:1500; Active Motif). The sections
were washed and labeled with Alexa dye-conjugated secondary antibodies.
Sections were mounted in ProLong Gold Antifade mounting media contain-
ing DAPI (Life Technologies). Negative controls included incubation with rab-
bit immunoglobulin G antibodies and omission of the primary antibody for all
samples. Quantification of sections for NuMA/VASA double staining was
determined manually from three to five independent 203 fields taken from
three different testis tissue depths and from at least three separate biological
replicates. Quantification of positive and negative 5-mC signals was deter-
mined by counting at least 150 NuMA+/VASA+ cells inside seminiferous
tubules across five 203 fields of view from two independent biological rep-
licates. For human testis cross-sections, 5-mC patterns were quantified in
only VASA+ cells inside tubules. Data for statistical analysis follow a normal
distribution.
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